Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation

Barish, Charles F., Drossman, Douglas, Johanson, John F., Ueno, Ryuji · 2010 · Digestive Diseases and Sciences

Abstract

Aims The aim of this study is to assess the efficacy and safety of lubiprostone in adults with chronic constipation. Methods This multicenter, parallel-group trial enrolled 237 patients with chronic constipation and randomized them to 4 weeks of double-blind treatment with oral lubiprostone 24 mcg or placebo twice daily. The primary efficacy endpoint was the number of spontaneous bowel movements (SBMs) after 1 week of treatment. Secondary evaluations included SBMs at weeks 2, 3, and 4; percentage of patients with a SBM within 24 h of first study dose; stool consistency; degree of straining; constipation severity; abdominal bloating and discomfort; global treatment effectiveness; and safety assessments. Results Lubiprostone-treated patients experienced greater mean numbers of SBMs at week 1 compared with placebo (5.89 versus 3.99, P = 0.0001), with significantly greater percentages having SBMs within 24 h of the first dose (61.3% versus 31.4%, P or =4 SBM per week) were significantly greater among lubiprostone-treated patients compared with placebo (P Conclusions In patients with chronic constipation, lubiprostone produced a bowel movement in the majority of individuals within 24 h of initial dosing, with sustained improvement in frequency as well as other constipation symptoms over 4 weeks of treatment.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10620-009-1068-x

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 13 references

Research works printed but not linked: 1

  1. Ueno R, Osama H, Habe T, et al. Oral spi-0211 increases intestinal fluid secretion and chloride concentration without altering serum electrolyte levels (abstract). Gastroenterology. 2004;126:298.

Cited by

See all 192

Metadata

Authors
Barish, C. F., Drossman, D., Johanson, J. F., & Ueno, R.
Affiliations
  • Wake Research (US)
  • University of North Carolina at Chapel Hill (US)
  • University of Illinois Chicago, Rockford campus (US)
Corresponding author
Barish, Charles F.
Venue
Digestive Diseases and Sciences
Published
2009-12-11
Volume
55
Issue
4
Pages
1090-1097
ISSN
  • 0163-2116 (ISSN-L)
  • 1573-2568
OpenAlex
W2003147380
Cited by
192
References
13
Citations by year
2026: 2 · 2025: 11 · 2024: 10 · 2023: 11 · 2022: 5 · 2021: 10 · 2020: 18 · 2019: 7 · 2018: 10 · 2017: 8 · 2016: 12 · 2015: 18 · 2014: 18 · 2013: 13 · 2012: 13
FWCI
13.24
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Digestive Diseases and Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
Keywords
lubiprostone, chronic constipation, prokinetic agents, spontaneous bowel movements, stool consistency, straining, bloating, gastrointestinal adverse effects, drug safety and efficacy
MeSH terms
Lubiprostone, Adult, Alprostadil, Chronic Disease, Constipation, Defecation, Double-Blind Method, Female, Follow-Up Studies, Humans, Male, Middle Aged, Treatment Outcome, Laxatives

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation. https://app.cochat.ai/papers/10.1007/s10620-009-1068-x
The paper
Barish, C. F., Drossman, D., Johanson, J. F., & Ueno, R. (2010). Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-009-1068-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.